The immediate impact of COVID-19 on clinical trials is now being overshadowed by the opportunities it presents to reimagine and reinvigorate studies.
As the capabilities of various systems improve over time, more widespread use of touchless processing will become feasible. Given that likely future, companies...
As the capabilities of various systems improve over time, more widespread use of touchless processing will become feasible. Given that likely future, companies can begin now to plan for and lay the groundwork for a touchless case processing system.
As the capabilities of various systems improve over time, more widespread use of touchless processing will become feasible. Given that likely future, companies can begin now to plan for and lay...
Due to an overwhelming response: Q&A follow-up to the inaugural CRO Roundtable.
Fundamental to ICH guidelines is the modernization of processes and technology to clinical trials with a focus on Quality by Design and risk-based management...
Fundamental to ICH guidelines is the modernization of processes and technology to clinical trials with a focus on Quality by Design and risk-based management approaches.
While simpler automation processes are able to replace routine or static human activity, AI systems are capable of analyzing data and applying specialized...
While simpler automation processes are able to replace routine or static human activity, AI systems are capable of analyzing data and applying specialized knowledge to the safety case process.
What is drug safety - a critical part of the clinical trial process and post-marketing management of a drug or device? And why is it important?
Clinical operations staff need to have confidence in machine learning predictive models and be able to validate the accuracy of outcomes.
With more companies responding to growing caseloads by using automation to streamline elements of the pharmacovigilance/multivigilance process, it’s useful for...
With more companies responding to growing caseloads by using automation to streamline elements of the pharmacovigilance/multivigilance process, it’s useful for safety professionals to understand the different options available.
With more companies responding to growing caseloads by using automation to streamline elements of the pharmacovigilance/multivigilance process, it’s useful for safety professionals to understand the...
ICH E6(R3) is coming at a time when organizations are struggling to adopt ICH E6(R2). But should organizations wait until these guidelines are ratified to...
ICH E6(R3) is coming at a time when organizations are struggling to adopt ICH E6(R2). But should organizations wait until these guidelines are ratified to realize the intended benefits?
